Yeh Fu-Chiang, Chen Hsiang-Cheng, Chou Yu-Ching, Lin Cheng-Li, Kao Chia-Hung, Lo Hsin-Yi, Liu Feng-Cheng, Yang Tse-Yen
Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Department of Health Promotion and Health Education, National Defense Medical Center, Taipei, Taiwan.
J Transl Med. 2020 Nov 30;18(1):455. doi: 10.1186/s12967-020-02629-w.
Ankylosing spondylitis (AS) is characterized by excessive production of inflammatory cytokines. Recent evidence suggests that inflammation underlies the neurodegenerative process of Parkinson's disease (PD). Whether AS has an influence on the development of PD is unclear. We aimed to examine a relationship, if any exists between AS and PD.
A population-based matched cohort study was performed using data from the 2000-2010 Taiwan National Health Insurance database. 6440 patients with AS and 25,760 randomly selected, age- and sex-matched controls were included in this study. The risk of PD in the AS cohort was evaluated by using a Cox model.
This study revealed a positive association between AS and the risk of PD regardless of sex and age (aHR 1.75, p < .001). Particularly, AS cohort to non-AS cohort relative risk of PD significantly increased for the patients aged below 49 and above 65 years (aHR 4.70, p < .001; aHR 1.69, p < .001, respectively) and the patients with and without comorbidities (aHR 1.61, p < .001; aHR 2.71, p < .001, respectively). Furthermore, NSAID use was associated with lower risk of PD (aHR 0.69, p < .05). However, the risk of PD was higher (aHR 2.40, p < .01) in patients with AS receiving immunosuppressants than in those not receiving (aHR 1.70, p < .001).
Patients with AS had an increased risk of PD which might be related to underlying chronic inflammation. Further research is required to elucidate the underlying mechanism.
强直性脊柱炎(AS)的特征是炎性细胞因子过度产生。最近的证据表明,炎症是帕金森病(PD)神经退行性过程的基础。AS是否会影响PD的发展尚不清楚。我们旨在研究AS与PD之间是否存在关系。
利用2000 - 2010年台湾国民健康保险数据库的数据进行了一项基于人群的匹配队列研究。本研究纳入了6440例AS患者和25760例随机选择的年龄和性别匹配的对照。通过Cox模型评估AS队列中患PD的风险。
本研究揭示,无论性别和年龄,AS与PD风险之间均呈正相关(风险比1.75,p <.001)。特别是,年龄在49岁以下和65岁以上的患者(风险比分别为4.70,p <.001;1.69,p <.001)以及有和无合并症的患者(风险比分别为1.61,p <.001;2.71,p <.001)中,AS队列相对于非AS队列患PD的相对风险显著增加。此外,使用非甾体抗炎药与较低的PD风险相关(风险比0.69,p <.05)。然而,接受免疫抑制剂治疗的AS患者患PD的风险高于未接受治疗的患者(风险比2.40,p <.01;风险比1.70,p <.001)。
AS患者患PD的风险增加,这可能与潜在的慢性炎症有关。需要进一步研究以阐明其潜在机制。